Integrated Theranostics Solutions
Industry Leading Experts in Molecular Imaging and Theranostics
Tailored strategies and solutions for your Theranostics needs.
Advanced imaging capabilities for precise diagnostics.
Strategic partnerships to enhance your business growth.
What is Theranostics?
Theranostics is a medical approach that combines therapy and diagnostics to to manage patients with cancer. It uses specific molecular imaging techniques to identify disease biomarkers and then employs targeted therapies based on those findings.
Today, Theranostics is approved for clinical use in patients with Neuroendocrine Tumors (NETs) or Metastatic Castration Resistant Prostate Cancer (mCRPC). In many cases, these therapies provide hope and another treatment option when others have failed.
The Future Looks Bright
Source: Oppenheimer & Co. Research
The pipeline of Theranostics agents is promising. While current FDA approvals are for Prostate Cancer and Neuroendocrine Tumors, many new drugs in development are for other cancer types including, breast, lung, melanoma, pancreatic, liver, colorectal, and others. The promise of this development pipeline provides hope for patients and expansion opportunities for a variety of medical groups and institutions.
BMC Cancer 23, 268 (2023). https://doi.org/10.1186/s12885-023-10725-5
Who We Are
Integrated Theranostics Solutions was founded with a singular mission: to bridge the gap between innovation and implementation, helping healthcare providers, researchers, and industry leaders navigate the complexities of Theranostics with strategic insights and tailored solutions.
Led by Adam Brown, a distinguished expert in nuclear medicine, molecular imaging, and theranostics, our firm provides strategic consulting and hands-on guidance to healthcare organizations, research institutions, and industry partners looking to establish and enhance their theranostics programs.
With a career spanning clinical practice, research, and industry leadership, Adam brings a wealth of expertise in imaging, therapy integration, regulatory compliance, research, and business strategy. He has played a pivotal role in the development of nationally recognized theranostics programs, advised on groundbreaking product innovations, and led teams in implementing sustainable and revenue-generating molecular imaging solutions.
At Integrated Theranostics Solutions, we offer tailored consulting and management services, including program assessment and optimization, patient care coordination, imaging and equipment integration, revenue cycle strategies, regulatory compliance, site design and readiness, and training programs designed to empower healthcare teams.
Whether you're launching a new theranostics program or seeking to optimize an existing one, our goal is to provide expert guidance that drives clinical excellence, operational efficiency, and business growth.
Let’s transform the future of personalized medicine—together.
